Search results
Zacks Research Comments on Bristol-Myers Squibb’s FY2024 Earnings (NYSE:BMY)
ETF DAILY NEWS· 21 hours agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities research analysts at Zacks Research issued their FY2024 earnings estimates for shares of Bristol-Myers Squibb in a report issued on Thursday ...
Bristol-Myers Squibb Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution
Simply Wall St. via Yahoo Finance· 7 days agoMany Bristol-Myers Squibb Company (NYSE:BMY) insiders ditched their stock over the past year, which...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 6 hours agoCytokinetics stock reversed higher Tuesday after safety worries clouded promising study results for...
Is Bristol Myers' Dividend in Danger?
The Motley Fool via AOL· 4 days agoBristol Myers Squibb (NYSE: BMY) pays investors an attractive dividend, which yields an incredibly high rate of 5.5%. That's nearly four times the S&P...
Bristol Myers Squibb Cancer-Treatment Trial Misses Endpoint
The Wall Street Journal· 4 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its...
News Highlights: Top Company News of the Day - Friday at 7 PM ET
Morningstar· 4 days agoBristol Myers Squibb said its trial evaluating a combination of cancer treatments failed to meet its primary endpoint. The television company, which produces "The Walking Dead," cited "declines ...
Bristol Myers Squibb reports setback in lung cancer trial By Investing.com
Investing.com· 4 days agoBristol Myers Squibb (NYSE: NYSE:BMY) disclosed that its Phase 3 CheckMate -73L trial for treating a...
One stock is dragging down the S&P 500's earnings growth
Yahoo Finance· 1 day agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings...
Insider Buying: BOERNER CHRISTOPHER S., Bristol-Myers Squibb Co. [BMY] Chief Executive Officer...
Knox Daily· 6 days agoThe buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Bristol-Myers Squibb Co. shares valued at $99,560 were purchased ...
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 5 days agoAt a time when drugmakers Eli Lilly & Co. and Novo Nordisk are scrambling to meet demand for their...
